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Aim: The rapid response system (RRS) is an in-hospital medical safety system. To date, not much is known about patient disposition
after RRS activation, especially discharge home. This study aimed to investigate the prevalence, characteristics, and outcomes of
patients with adverse events who required RRS activation.
Methods: Retrospective data from the In-Hospital Emergency Registry in Japan collected from April 2016 to November 2020 were
eligible for our analysis. We divided patients into Home Discharge, Transfer, and Death groups. The primary outcome was the preva-
lence of direct discharge home, and independently associated factors were determined using multivariable logistic regression.
Results: We enrolled 2,043 patients who met the inclusion criteria. The prevalence of discharge home was 45.7%; 934 patients were
included in the Home Discharge group. Age (adjusted odds ratio [AOR] 0.96; 95% confidence interval [CI], 0.95–0.97), malignancy (AOR
0.69; 95% CI, 0.48–0.99), oxygen administration before RRS (AOR 0.49; 95% CI, 0.36–0.66), cerebral performance category score on
admission (AOR 0.38; 95% CI, 0.26–0.56), do not attempt resuscitation order before RRS (AOR 0.17; 95% CI, 0.10–0.29), RRS call for res-
piratory failure (AOR 0.50; 95% CI, 0.34–0.72), RRS call for stroke (AOR 0.12; 95% CI, 0.03–0.37), and intubation (AOR 0.20; 95% CI,
0.12–0.34) were independently negative, and RRS call for anaphylaxis (AOR 15.3; 95% CI, 2.72–86.3) was positively associated with dis-
charge home.
Conclusion: Less than half of the in-hospital patients under RRS activation could discharge home. Patients’ conditions before RRS
activation, disorders requiring RRS activation, and intubation were factors that affected direct discharge home.
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INTRODUCTION
ADVERSE EVENTS DURING hospitalization haveinfluenced increased mortality, hospital stays, and costs,
which is unfortunate for patients and/or their families.1,2 The
rapid response system (RRS) is shown to effectively function
as an in-hospital medical safety system to identify signs of
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imminent clinical deterioration on nonintensive care wards
with the purpose of prevention of further life-threatening
events.3,4 Patients with in-hospital adverse events are less
likely to be discharged home.5 Nevertheless, discharge to
home is the ultimate goal for all clinicians and patients and/or
their families due to patient satisfaction, quality of life, and
socioeconomic costs.6–9 Although the Japanese government
has proposed constructing a comprehensive home medical
care system due to its rapidly aging society, few studies have
investigated the outcomes of in-hospital serious adverse
events requiring RRS; limited data exist, especially regarding
discharge to home in this cohort.5,10
We undertook a large-scale, retrospective, cohort study
using data from a Japanese RRS registry to investigate the
prevalence, characteristics, and outcomes focused on dis-
charge home for patients with serious adverse events who
received RRS activation. Sharing our study could help emer-
gency physicians make better patient care plans for those
suffering from unfortunate in-hospital adverse events.
METHODS
In-Hospital Emergency Registry in Japan
THE In-Hospital Emergency Registry in Japan (IHER-J) is a registered database for the RRS in Japan
(UMIN000012045) managed by the Japanese Society of
Intensive Care Medicine and the Japanese Society of Emer-
gency Medicine. The number of institutions comprising the
IHER-J online registry has increased to 32 in Japan (nine
university hospitals and 23 community hospitals). All partic-
ipating hospitals used similar, predefined criteria for RRS
activation, including thresholds for breathing, airway status,
consciousness, circulation, and other factors (e.g., inability
to contact the patient’s physician or staff concern).11 All
patients with RRS activation were entered into the IHER-J
database at each participating hospital.
Study design, setting, and subjects
This study was approved by a suitably constituted ethics
committee of our institution (Committee of Okayama Sai-
seikai General Hospital, ID 201201), and it conforms to the
provisions of the Declaration of Helsinki. Patient consent
was waived.
This study was undertaken using retrospective, observa-
tional data collected through the IHER-J online registry
form. Patients with activated RRS from April 2016 to
November 2020 were eligible for our analysis. Cases involv-
ing outpatients, patients with cerebral performance category
(CPC) scores of 3 or higher on admission, patients under
20 years old, and patients with incomplete outcome data
were excluded.
Data collection
We collected the following data from the RRS registry: base-
line patient data (age, sex, admitted disorder, admitted
department, intensive care unit [ICU] admissions, oxygen
administration, do not attempt resuscitation [DNAR] order,
operation before RRS, and CPC score on admission), RRS
activation data (time course, medical status of the caller,
activated reason, diagnosed disorder after activation, inter-
ventions by medical emergency teams [METs]), and out-
comes (CPC score, length of hospital stay, DNAR orders
after RRS, and disposition after RRS activation and at dis-
charge).
Patient grouping and end-point
We compared three patient groups who received RRS activa-
tion in the participating hospitals: the Home Discharge group
(patients who were directly discharged home), the Transfer
group (patients who were discharged to other hospitals or
nursing facilities), and the Death group (patients who died in
the hospital) based on discharge status. The primary outcome
was the prevalence of direct discharge home. Secondary out-
comes included CPC score, length of hospital stay, DNAR
orders, and disposition after RRS activation. Additionally,
factors associated with discharge home were evaluated.
Data analysis
Continuous variables were described using medians with
interquartile ranges (IQR). Categorical variables were
described using percentages. We compared variables across
groups using one-way ANOVA for numerical variables and
the v2-test for categorical variables. Multivariable logistic
regression was used to adjust covariates (age, sex, post-ICU,
oxygen administration, CPC score, DNAR order, pre-existing
conditions, time course of RRS, diagnosed disorder related to
RRS, and interventions by METs) to evaluate factors con-
tributing to discharge home. Logistic regression analysis
results were expressed using odds ratios (ORs) and 95% confi-
dence intervals (CIs). Statistical analysis was carried out using
Stata version 17 (StataCorp, College Station, TX, USA). P-
values below 0.05 were considered statistically significant.
RESULTS
FIGURE 1 shows our study design flow chart. Duringthe approximately 4-year period, 4,782 cases were
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registered. After excluding patients under 20 years of age
(n = 182), outpatients (n = 943), and cases with CPC score
3–5 (n = 547) and incomplete data (n = 1,067), 2,043 cases
met the inclusion criteria; prevalence of discharge home was
45.7%; 934 patients were included in the Home Discharge
group. The Transfer group and Death group included 432
patients (21.1%) and 677 patients (33.2%), respectively.
Table 1 shows the patients’ baseline characteristics. The
Home Discharge group was younger (median age, 71 years
[IQR, 56–79 years]), had a higher proportion of CPC scores
of 1 (90.7%), and had fewer DNAR orders before RRS
(3.5%) than the Transfer and Death groups. The proportions
of patients in the Home Discharge group with malignancy
and oxygen administration before RRS were 14.2% and
35.1%, respectively. Overall, approximately half of the cases
(1,075/2,043 [52.6%]) were admitted to medical depart-
ments.
Table 2 shows the baseline characteristics of patients who
received RRS activation. The RRS activation call criteria
including agitation (2.4%) was higher, while desaturation
(22.2%) was lower in the Home Discharge group. There
were multiple criteria for RRS activation; the median num-
ber of RRS activation call criteria was 1 (IQR, 1–2) in the
Home Discharge group. Rapid response system activation
disorders including anaphylaxis (3.3%) were higher, while
asphyxia (3.7%), respiratory failure (14.8%), and stroke
(1.3%) were lower in the Home Discharge group. Table 3
shows outcomes after RRS. The proportion of CPC scores
of 1 was 85.1% in the Home Discharge group. Length of
hospital stay was shorter in the Home Discharge group
(17 days (IQR, 10–28). Furthermore, the proportion of
newly announced DNAR orders (0.8%) was lower in the
Home Discharge group. In multivariable analysis, age (ad-
justed odds ratio [AOR] 0.96; 95% CI, 0.95–0.97;
P < 0.001), malignancy (AOR 0.69; 95% CI, 0.48–0.99;
P = 0.050), oxygen administration before RRS (AOR 0.49;
95% CI, 0.36–0.66; P < 0.001), CPC score on admission
(AOR 0.38; 95% CI, 0.26–0.56; P < 0.001), DNAR order
before RRS (AOR 0.17; 95% CI, 0.10–0.29; P < 0.001),
RRS call for respiratory failure (AOR 0.50; 95% CI, 0.34–
0.72; P < 0.001), RRS call for stroke (AOR 0.12; 95% CI,
0.03–0.37; P < 0.001), and intubation (AOR 0.20; 95% CI,
0.12–0.34; P < 0.001) were independently negatively asso-
ciated with discharge home. Rapid response system call for
anaphylaxis (AOR 15.3; 95% CI, 2.72–86.3; P = 0.002)
was positively associated with discharge home (Table 4).
DISCUSSION
IN THIS population-based study of IHER-J data, wefound that the prevalence of direct return home on dis-
charge was only 45.7%. Age, malignancy, oxygen adminis-
tration before RRS, CPC score on admission, DNAR order
before RRS, and RRS call for respiratory failure and stroke
were independently negatively associated with discharge
home, while RRS call for anaphylaxis was independently
positively associated with discharge home.
Few published reports describe the outcomes of patients
with adverse events who required RRS activation and were
discharged home.5 In prospective data, the prevalence of dis-
charge home after receiving RRS activation was approxi-
mately 50%, consistent with our results, while the prevalence
of discharge home after hospitalization was 86.8%.5,12 These
results indicate that adverse events were associated with less
frequency of discharge home. There might be several reasons
for the low frequency of discharge home after hospitaliza-
tion. First, patients who recover from in-hospital serious
adverse events might suffer from impaired activities, generat-
ing a reduced perception of well-being in affected individu-
als.6,8 Physical function, health status, and socioeconomic
status at hospital discharge have been identified as risk fac-
tors affecting patients’ return to home.6,8 Our results revealed
that CPC scores on hospital discharge were different between
the groups. Second, the potential lack of medical staff or
other resources needed, including financial issues, might pre-
vent home-based long-term care for these patients nation-
wide in our medical system.13
Our study revealed that malignancy and code status were
negatively associated with home discharge. Approximately
Fig. 1. Flowchart of the cohort study design to determine the
prevalence and predictors of direct discharge home of inpa-
tients managed by the rapid response system in Japan. CPC,
cerebral performance category; IHER-J, In-Hospital Emergency
Registry in Japan.
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31.1% of patients with end-of-life care who received RRS
activation received limited medical therapy; only 22.4% of
these patients were discharged home in the prospective
study.5 Brown et al. described 30.0% of in-hospital patients
with end-of-life care due to advanced cancer who received
RRS activation.14 Other studies indicated the effectiveness
of MET intervention for increased completion of limited
medical treatment orders, DNAR orders, instigation of
patient and family meetings, and end-of-life discussions.14,15
Our study revealed that patients who were not discharged
home were more likely to have a DNAR order established.
Medical emergency teams could help improve end-of-life
care by communicating the goals for quality end-of-life, and
accepting end-of-life for patients with malignancy and
DNAR orders.
Our results showed that patients with adverse events who
suffered from respiratory failure and stroke requiring RRS
activation had a lower chance of home return. Va et al.
described the incidence of home discharge as 163/279
(58.4%) in patients 50–70 years old and 18/96 (18.8%) in
those over 80 years old with the use of mechanical ventila-
tion.16 The diagnosis of polyneuropathy and/or myopathy,
including ICU-acquired weakness caused by respiratory fail-
ure, is another general factor strongly associated with
reduced discharge home.17 The influence of stroke on daily
functioning and quality of life can affect discharge home.
Time is a critical factor in the treatment of acute strokes,
both hemorrhagic and ischemic.18 Rapid response systems
specialized in stroke help to reduce in-hospital treatment
delay, although the effect of discharge home is unknown.18
Our results also revealed that patients with RRS call for
anaphylaxis had a higher chance of home return regardless
of the pathology. There has been a worldwide increase in
all-cause anaphylaxis cases, primarily driven by food and
medication-related anaphylaxis; fatal anaphylaxis constitutes
less than 1% of mortality risk.19 However, delayed adrena-
line injection is associated with fatal outcomes.20 In general,
pediatric METs were frequently required for anaphylaxis.21
The RRS is designed for early recognition of deterioration
and administration of resuscitation to clinically unstable
patients. Previous studies have indicated that RRS imple-
mentation could reduce the incidence of unplanned ICU
admission, cardiac arrest, hospital death, and hospital mor-
tality.3,4 We could not compare the institutions with or
Table 1. Characteristics of inpatients treated by medical emergency teams (n = 2,043)
Home discharge (n = 934) Transfer (n = 432) Death (n = 677) All (n = 2,043) P-value
Clinical information
Male gender 525 (56.2) 233 (53.9) 424 (62.6) 1,182 (57.8) 0.006
Age, years 71 (56–79) 79 (70–86) 76 (67–83) 75 (64–83) <0.001
Postoperative 196 (21.0) 106 (24.5) 471 (6.9) 349 (17.1) <0.001
Post-ICU 44 (4.7) 32 (7.4) 29 (4.2) 105 (4.9) 0.052
Oxygen administration 324 (35.1) 184 (32.4) 446 (66.8) 954 (47.2) <0.001
CPC score on admission
CPC1 848 (90.7) 318 (73.6) 524 (77.4) 1,689 (82.7) <0.001
CPC2 87 (9.3) 114 (26.4) 153 (22.6) 354 (17.3) <0.001
DNAR order 24 (3.5) 38 (13.4) 128 (23.0) 190 (12.6) <0.001
Admitted department
Medical 470 (50.3) 168 (38.8) 437 (64.6) 1,075 (52.6) <0.001
Surgical 202 (21.6) 65 (15.0) 113 (16.6) 380 (18.6) 0.004
Neurosurgery 33 (3.5) 39 (9.0) 24 (3.5) 90 (4.7) <0.001
Psychiatric, n 5(0.5) 1 (0.2) 2 (0.2) 8 (0.3) 0.624
Obstetrics and gynecology 65 (6.9) 5 (1.1) 19 (2.8) 89 (4.3) <0.001
Emergency 13 (1.3) 21 (4.8) 16 (2.3) 50 (2.4) 0.001
Othersa 122 (13.0) 131 (30.3) 55 (8.1) 308 (15.0) <0.001
Pre-existing conditions
Infection 62 (6.6) 25 (5.7) 51 (7.5) 138 (6.7) 0.518
Malignancy 133 (14.2) 32 (7.4) 168 (24.8) 333 (16.2) <0.001
Note: Continuous variables are presented as median (interquartile range), categorical variables are shown as n (%). P-values were calculated
using v2 analysis or ANOVA.
aIncluding Dermatology, Urology, and Orthopedics.
CPC, cerebral performance category; DNAR, do not attempt resuscitation; ICU, intensive care unit.
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Weekday 764 (81.7) 346 (80.1) 539 (79.6) 1,649 (80.7) 0.512
Weekend 170 (18.3) 86 (19.9) 138 (20.4) 394 (19.3) 0.512
Call occupation
Physician 257 (27.8) 66 (15.3) 202 (30.9) 525 (26.2) <0.001
Nurse 634 (68.8) 353 (82.2) 442 (67.7) 1,429 (71.3) <0.001
Time course
Time from call to MET arrival, min 5 (3–8) 3 (5–10) 4 (2–8) 5 (3–8) 0.192
Duration of MET activation, min 30 (18–53) 30 (20–55) 35 (20–59) 31 (20–56) 0.311
Call criteria for RRS
Respiratory
Dyspnea 92 (9.8) 41 (9.4) 82 (12.1) 215 (10.5) 0.252
Bradypnea 17 (1.8) 10 (2.3) 60 (8.8) 87 (4.2) <0.001
Tachypnea 119 (12.7) 53 (12.2) 131 (19.3) 303 (14.8) <0.001
Desaturation 208 (22.2) 130 (30.0) 279 (41.2) 617 (30.1) <0.001
Circulatory
Hypotension 285 (30.4) 95 (21.9) 214 (31.6) 594 (29.0) 0.001
Bradycardia 52 (5.5) 10 (2.3) 77 (11.3) 139 (6.8) <0.001
Tachycardia 95 (10.1) 63 (14.5) 69 (10.1) 227 (11.1) 0.035
Neurology
Altered mental status 205 (21.9) 110 (25.4) 258 (38.1) 573 (28.0) <0.001
Seizure 24 (2.5) 10 (2.3) 10 (1.4) 44 (2.1) 0.318
Agitation 23 (2.4) 3 (0.6) 5 (0.7) 31 (1.5) 0.006
Other
Nurse concern 157 (16.7) 81 (18.7) 95 (14.0) 333 (16.2) 0.099
Delayed reaction 32 (3.4) 12 (2.7) 10 (1.4) 54 (2.6) 0.054
Decreased urine output 21 (2.2) 10 (2.3) 19 (2.8) 50 (2.4) 0.759
Chest pain 23 (2.4) 15 (3.4) 3 (0.4) 41 (2.0) 0.001
Number of RRS activation
reasons
1 (1–2) 1 (1–2) 2 (1–3) 1 (1–2) <0.001
Disorder for RRS
Anaphylaxis 31 (3.3) 3 (0.6) 0 (0) 34 (1.6) <0.001
Asphyxia 35 (3.7) 45 (10.4) 67 (9.8) 147 (7.1) <0.001
Respiratory failure 139 (14.8) 76 (17.5) 205 (30.2) 420 (20.5) <0.001
Hemorrhagic shock 74 (7.9) 20 (4.6) 39 (5.7) 133 (6.5) 0.045
Sepsis 138 (14.7) 43 (9.9) 123 (18.1) 304 (14.8) 0.001
Heart failure 52 (5.5) 24 (5.5) 47 (6.9) 123 (6.0) 0.467
Myocardial infraction 21 (2.2) 4 (0.9) 15 (2.2) 40 (1.9) 0.219
Pulmonary embolism 8 (0.8) 4 (0.9) 10 (1.4) 22 (1.0) 0.464
Stroke 12 (1.2) 21 (4.8) 20 (2.9) 53 (2.5) <0.001
Intervention
Test order 436 (49.1) 210 (50.6) 308 (48.6) 954 (49.3) 0.821
Oxygen administration 274 (31.1) 134 (32.8) 309 (48.5) 717 (37.2) <0.001
Fluid bolus 199 (22.6) 72 (17.6) 200 (31.6) 471 (24.5) <0.001
Medication 280 (31.7) 111 (27.0) 249 (39.7) 640 (33.3) <0.001
Suction 45 (5.1) 54 (13.3) 142 (22.8) 241 (12.6) <0.001
BVM 60 (6.8) 37 (9.0) 173 (27.5) 270 (13.9) <0.001
NPPV 30 (3.4) 18 (4.4) 44 (6.9) 92 (4.8) 0.006
Intubation 52 (5.9) 23 (5.6) 175 (27.7) 250 (13.0) <0.001
© 2021 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of
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without the RRS registry in this study; however, the effec-
tiveness of RRS in contributing to return home on discharge
following in-hospital adverse events should be evaluated in
the future.
Our study has several limitations. First, we could not
obtain detailed information about the patients’ residence
(home/nursing facility/hospital) before hospital admission;
some of RRS activated patients could have been transported
from other hospitals or nursing facilities. Second, this study
analyzed national registry data, which included records from
only 32 participating institutions. Thus, some of the study
findings might not be generalizable to all institutions. Third,
home discharge is not necessarily synonymous with
functional recovery; however, it can be a summative mea-
sure of short-term outcomes representing restoration of qual-
ity of life. Fourth, we could not obtain sufficient detailed
follow up information on deterioration on discharge. Finally,
the cases discharged to nursing homes or transferred to
another hospital might eventually return home.
CONCLUSIONS
IN OUR ANALYSIS, less than half of in-hospital patientswho received RRS activation could directly discharge
home from the hospital. Age, malignancy, code status, CPC












CPR 13 (1.4) 4 (0.9) 90 (14.2) 107 (5.5) <0.001
Defibrillation 9 (1.0) 6 (1.4) 28 (4.4) 43 (2.2) <0.001
Transfusion 52 (5.9) 16 (3.9) 31 (4.9) 99 (5.1) 0.311
Note: Continuous variables are presented as median (interquartile range); categorical variables are shown as n (%). P-values were calculated
using v2 analysis or ANOVA.
BVM, bag valve mask; CPR, cardiopulmonary resuscitation; MET, medical emergency team; NPPV, noninvasive positive pressure ventila-
tion.
Table 3. Outcomes of patients who were treated by medical emergency teams (n = 2,043)
Home discharge (n = 934) Transfer (n = 432) Death (n = 677) All (n = 2,043) P-value
Outcomes
Disposition after RRS activation
ICU transfer 257 (27.5) 87 (20.1) 246 (36.4) 590 (28.9) <0.001
Stay in ward 550 (58.9) 290 (67.1) 274 (40.6) 1,114 (54.6) <0.001
Death 0 (0) 0 (0) 107 (15.8) 107 (5.2) <0.001
DNAR order after RRS 29 (3.8) 45 (13.4) 236 (37.8) 310 (18.0) <0.001
New DNAR order after RRS 5 (0.8) 4 (1.6) 66 (15.8) 75 (5.8) <0.001
CPC score
CPC1 790 (85.1) 190 (44.3) 0 (0.0) 980 (48.2) <0.001
CPC2 123 (13.2) 147 (34.3) 0 (0.0) 270 (13.2) <0.001
CPC3 15 (1.6) 85 (19.8) 0 (0.0) 100 (4.9) <0.001
CPC4 0 (0.0) 6 (1.4) 0 (0.0) 6 (0.2%) <0.001
CPC5 0 (0.0) 0 (0.0) 677 (100) 677 (33.3) <0.001
Hospital length of stay, days 17 (10–28) 27 (18–38) 22 (10–39) 21 (12–33) 0.001
Note: Continuous variables are presented as median (interquartile range); categorical variables are shown as n (%). P-values were calculated
using v2 analysis or ANOVA.
CPC, cerebral performance category; ICU, intensive care unit; DNAR, do not attempt resuscitation; RRS, rapid response system.
© 2021 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of
Japanese Association for Acute Medicine
6 of 8 T. Hongo et al. Acute Medicine & Surgery 2021;8:e690
RRS activation were negative factors and anaphylaxis before
RRS activation was a positive factor affecting direct dis-
charge home from the hospital.
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APPENDIX 1
COLLABORATORS OF THE IN-HOSPITAL
EMERGENCY STUDY GROUP
ST. MARIANNA UNIVERSITY Hospital (Shigeki Fuji-tani); Tokyo Bay Urayasu/Ichikawa Medical Center
(Yoshihisa Fujimoto); NHO Ureshino Medical Center (Shin-
suke Fujiwara); Kitazato University Hospital (Masayasu
Arai); Osaka City General Hospital (Morooka Takaya); Mie
University Hospital (Eiji Kawamoto); Nagoya City Univer-
sity Graduate School of Medical Sciences (Yoshiki Sento);
Kyoritsu General Hospital (Yuta Kawase); Kobe City
Medical Center General Hospital (Kazuma Nagata); Fukush-
ima Medical University Aizu Medical Center (Takuro
Saito); Tomishiro Central Hospital (Masahiro Tamashiro);
St. Luke’s International Hospital (Kazuhiro Aoki); Hyogo
College Of Medicine College Hospital (Atsushi Miyawaki);
Jichi Medical University Saitama Medical Center
(Tomoyuki Masuyama); Shizuoka Children’s Hospital (Tat-
suya Kawasaki); Japanese Red Cross Musashino Hospital
(Takuya Kawaguchi); Seirei Hamamatsu General Hospital
(Takahiro Atsumi); Hikone Municipal Hospital (Tomoyuki
Ikeda); Shimane Prefectural Central Hospital (Yuji Yama-
mori); Kameda Medical Center (Yoshiro Hayashi); Kura-
shiki Central Hospital (Takanao Otake); Gunma University
Hospital (Masaru Tobe); Okayama Saiseikai General Hospi-
tal (Toshifumi Fujiwara); Ibaraki Prefectural Central Hospi-
tal (Ryosuke Sekine); Chiba University Graduate School of
Medicine (Takaaki Nakada); Chikamori Hospital (Kazuhiko
Sugimoto); Northern Okinawa Medical Center (Hiroshi
Onozawa); Kainan Hospital (Kentaro Miyake); National
Hospital Organization Nagasaki Medical Center (Chikaaki
Nakamichi); Hitachi General Hospital (Naraba Hiromu);
Yokosuka General Hospital Uwamachi (Jun Makino);
Fukuyama City Hospital (Kenzo Ishii); Nara City Hospital
(Yasunobu Goto); Mito Saiseikai General Hospital (Hitoshi
Kikuchi); Tokushima Red Cross Hospital (Tadaaki Takada);
Kin-ikyo Chuo Hospital (Dai Taguchi); Fukuyama City
Hospital (Kenzo Ishii); Dokkyo Medical University (Eisei
Hoshiyama); Daiyukai General Hospital (Hiromichi
Miyabe); Tottori Prefectural Central Hospital (Masaru Oka-
moto); Kyoto Okamoto Memorial Hospital (Masahiro
Koide); Jikei University School of Medicine Kashiwa
Hospital (Yoichi Kase); Jikei University School of Medicine
(Yoichi Kase); Kansai Electric Power Hospital (Takuya
Hashino); Saitama Children’s Medical Center (Takehiro
Niitsu); Shinshu University Hospital (Hiroshi Kamijo).
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